Pfizer’s board of directors has elected CEO Jeff Kindler as its chairman, succeeding Hank McKinnell. McKinnell will step down from the Board when he leaves the company in February.
The Board of Directors of Merck has elected CEO Richard Clark as chairman of the board effective April 24, 2007, the date of the Merck annual meeting of stockholders. Clark has been CEO of Merck since May 2005. The board also appointed Samuel Thier as lead director.
GlaxoSmithKline named Adrian Rawcliffe SVP, worldwide business development, research & development, effective immediately. Rawcliffe most recently served as managing partner and president, SR One Ltd., GSK's venture-capital business.
Valeritas, a subsidiary of BioValve Technologies, has hired Tara Charvat as VP of marketing and marketing operations. Charvat joins the company with a diverse background in pharmaceutical marketing, having held key positions
at Saatchi & Saatchi Healthcare Advertising, Publicis Medical Education Group, and Abbott Laboratories. In her newly created position, Charvat will play a major role in creating innovative, integrated promotional campaigns for Valeritas' metabolic portfolio of products as well as coordinating the company's product marketing programs. Her immediate priority will be to develop and execute an integrated marketing plan for the company's lead product, h-Patch insulin delivery system, which is scheduled for commercial launch in the second half of 2007, the company said in a statement.
Imc²'s Philadelphia office has hired five additional employees -- Lisa Eckel, Jeanille Tumey and Danielle Brose join as project managers; Karen Angelucci joins as an account manager, while Yvonne Connolly serves as an executive assistant.
IMS Health elected Bret Wise, president and COO of Dentsply International, to its board of directors, effective immediately.
This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.